Potential Healthcare Stocks That Are Making Investors Insane About The Profit
Universal Ibogaine is working with Health Canada to undertake a planned clinical trial in Canada to demonstrate the safety and efficacy of the Ibogaine treatment protocol for opioid use disorder.
$IBOGF has established a remarkable market cap as compared to its fellow penny stocks in the market, currently the market cap is valued at $9.07 Million which has increased twice within a week.
At the Kelburn Clinic, UI is developing a cutting-edge holistic addiction treatment protocol that, when combined with the anticipated ibogaine detox programme, will transform the way we treat addiction and dramatically enhance the lives of individuals and families plagued by addiction.
"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." Alike Blue Digital Media’s expertise radar
Universal Ibogaine Inc. CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedelic medications, Germany has a reputation for...
With the current buyout price of $0.095, the company has around 6.5 million+ market cap, proliferating exponentially. Add the life science-based stock in your watch list and boost your portfolio.
Dr. Sola, a co-founder of Universal Ibogaine and a member of its Board of Directors, has effectively administered over 3,700 ibogaine treatments, more than any other doctor in the world, at an independent clinic in Cancun, Mexico, where he is a partner.
Blue Digital will be paid USD 27,000 for a three-month commitment beginning June 13, 2022. Additionally, Blue Digital will get 450,000 company's stock options to purchase common shares of the Company, with an exercise price of $0.10 per share, a three-year term, and one-third vesting at the conclusion of each month of service.
#tatapower trading near inflection point , if hold 200 then opportunity and if break 200 then chart destruction .
#TATAPOWER Time to short this one now great levels to gain huge profits. Energy sector showing weakness after a great really. TATA power at crucial Support levels. Short below 204. Stop loss 208 Targets 1st - 185 2nd - 170 3rd - 140. Strong conviction. #short #sell @Equities @tradingview_ @vivek_mashrani @Shorting @forextidings @Tredingview
Analysis is done only for educational purpose. Don't trade directly or blindly on levels. Make sure you have your own study before entering into trade. Before Investing in this script make sure to do consult with your Financial-Advisor. Risk & Reward both belong to you so take steps wisely.
Universal Ibogaine Inc. is a life science company listed on OTC with the ticker symbol $IBOGF, currently sits at $0.0341 with the average market volume of 5k+
The offering constituting the private non-brokered placement of 15 Million units is only available to existing shareholders of the company, who as of the closing of business on May 16, 2022 hold common shares of Hemostemix
Dr. Alberto Sola, the co-founder of $IBOGF is going to present his latest findings in a panel titled “Ibogaine Hydrochloride and Acute Opioid Detox”.
Long term Investment levels for Axis Bank...💸💵 refer levels in chart...
Hemostemix Inc. announced that it will pay interest of $84,804.40 by issuing 446,339 Common Shares, using the March 2, 2022 closing price of $0.19 per share, to the convertible debenture holder in satisfaction of interest due on the outstanding principal amount of $2,500,000 for the period from inception, June 11, 2021, to December 31, 2021.
The company has filled out all the space of security data over the OTC market with a total of 190.7 million as the share outstanding, out of which 70.15 million has been issued and allowed for publicly-traded activities viewed as share float. $IBOGF currently lands on a 6.5 million market cap. Boost your portfolio with $IBOGF, trading on the OTC platform.